Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11382960 High frequency application of botulinum toxin therapy

Patent 11382960 was granted and assigned to Merz Pharma on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Merz Pharma

Current Assignee

Merz Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11382960

Patent Inventor Names

Dirk Dressler0

Matthias Marx0

Reiner Benecke0

Susanne Grafe0

Date of Patent

July 12, 2022

Patent Application Number

17009082

Date Filed

September 1, 2020

Patent Citations

‌

US Patent 10792344 High frequency application of botulinum toxin therapy

‌

US Patent 10688162 Hybrid neurotoxins and uses thereof

Patent Primary Examiner

‌

Nita M. Minnifield

The present invention relates to methods for treating diseases and disorders by administering a composition containing the neurotoxic component of a

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11382960 High frequency application of botulinum toxin therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API